Ocular Therapeutix, Inc.
OCUL
$7.45
-$0.49-6.17%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -65.60% | -6,972.29% | -111.67% | -113.89% | -88.01% |
| Total Depreciation and Amortization | -0.73% | 7.75% | 46.63% | 90.48% | 95.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -42.16% | 101.30% | 228.31% | 248.23% | 5,321.49% |
| Change in Net Operating Assets | 113.09% | -119.46% | 168.34% | -420.28% | -206.93% |
| Cash from Operations | -75.60% | -372.83% | -23.55% | -69.66% | -32.41% |
| Capital Expenditure | 55.99% | 65.64% | 62.71% | 92.45% | 78.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 55.99% | 65.64% | 62.71% | 92.45% | 78.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.83% | 442.60% | -77.23% | 411,724.36% | 23,517.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.83% | -91.96% | -77.23% | 411,724.36% | 23,517.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.19% | -173.89% | -87.99% | 1,333.48% | 557.14% |
